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Abstract
We have extended our recently developed 2-step approach for gene-based analysis to the family design and to
the analysis of rare variants. The goal of this approach is to study the joint effect of multiple single-nucleotide
polymorphisms that belong to a gene. First, the information in a gene is summarized by 2 variables, namely the
empirical Bayes estimate capturing common variation and the number of rare variants. By using random effects for
the common variants, our approach acknowledges the within-gene correlations. In the second step, the 2
summaries were included as covariates in linear mixed models. To test the null hypothesis of no association, a
multivariate Wald test was applied. We analyzed the simulated data sets to assess the performance of the method.
Then we applied the method to the real data set and identified a significant association between FRMD4B and
diastolic blood pressure (p-value = 8.3 × 10-12).
Background
Testing for the joint effect of single-nucleotide polymorph-
isms (SNPs) located in a gene is a popular alternative to
single-marker tests. Single SNP methods are underpow-
ered because single SNPs have typically small effect sizes
(common variants) or small minor allele frequencies
(MAFs) (rare variants). In contrast, approaches that model
the combined effect of multiple SNPs will be more power-
ful. Recently, we have proposed a method consisting of 2
steps [1,2]: (a) the dimensionality of the genetic data is
reduced, and gene-specific summaries are produced, and
(b) these summaries are introduced as covariates in the
model for the phenotype. To model the correlation among
SNPs within a gene, we use a generalized linear mixed
model for the SNPs. A gene-level random effect captures
the correlation within each gene. The empirical Bayes esti-
mates of the random effects per subject and gene are used
as summary measures of the SNPs data and are included
in the phenotype model to test for association.
For the Genetic Analysis Workshop 17 (GAW17), we
studied the performance of this approach for the
sequence data on the families [2]. The conclusion was
that common variants were well represented by this gene
summary, but variation due to rare variants was not well
captured. For rare variants several collapsing methods
have been developed (see [3] for an overview).
Using the GAW18 data, we extend our 2-step method
to the combined familial and longitudinal setting. Next to
the empirical Bayes estimates, we will also consider the
total number of rare variants (MAF < 0.05) to summarize
the information on rare SNPs within a gene. Using the
200 simulated data sets, we assess the power of our
approach for genes with functional loci. We compare
results obtained by using the original Variant Call Format
(VCF) files as well as the files in which the genotypes of
relatives having only genome-wide association (GWA)
data were imputed. Gene summaries will be computed
based on all variants and based on only functional var-
iants. For the simulated data sets, we assume that both
gene effects are constant over time. Finally, we present
the results of analyzing the true data set for associations
with diastolic blood pressure (DBP). In this data set, we
have identified one significant result when using the VCF
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files, assuming no interactions between gene summaries
and time, and 2 borderline significant associated genes
when we included an interaction between time and gene
effects to allow gene effects to change over time. Because




We considered data for 959 individuals from 20 families.
Of these, 464 are directly sequenced individuals; for their
family members, imputed WGS data based on the exist-
ing GWA framework were available. In this article, we
restrict ourselves to genotypic data from chromosome 3.
For each individual, we have information on age at exam-
ination and current tobacco smoking (yes = 1; no = 0) for
up to 4 time points for real data and for up to 3 points
for the simulated data. We analyzed the quantitative trait
DBP. There are 1274 genes on chromosome 3. From
these, 927 and 929 genes contain at least one rare variant
for the imputed files and one for the VCF files. When
restricting the analysis to functional variants, these num-
bers are 46 and 43, respectively. To extract genes, we
used the R packages GenomicFeatures and RSQLite from
Bioconductor. We used the tool ANNOVAR [4] with the
UCSC Known Genes database [5] to select the exonic
SNPs and their predicted effect on the protein. If this
effect is known and not synonymous (e.g., nonsynon-
ymous, or stop codon introducing or removal), the SNP
was considered functional. See Almasy et al [6] for a
more extended description of the data set.
Model specification
Let yijt be the outcome variable for individual j from
family i at time point t. For a specific gene g, let wijgs be
the genotype at SNP s (s = 1,..., S). The genotype wijgs is
coded 0, 1, or 2. For individual j of family i, let xijt be
vectors with covariate values for the phenotypes (age
and smoking status).
Gene summaries
We assume that Hardy Weinberg equilibrium holds. We
consider a random gene effect to model the correlation
among SNPs within a gene. Let bjg be the random gene
effect of gene g for subject j. Given this random effect, wijgs,
the number of minor variants for SNP s in gene g is assumed
to follow a binomial distribution with n = 2 trails and prob-
ability πijgs. The probability πijgs is modeled as follows:
log
πijgs
1 − πijgs = α + bjg, (1)
where bjg follows a normal distribution with zero
mean and variances s2. For each individual and each
gene, the empirical Bayes estimate is given by ebˆijg = bˆjg.
Intuitively, the value of the empirical Bayes estimate will
increase with the number of variants a subject carries.
These models are fitted using the package lme4 in R.
Because rare variants are not well captured by the
empirical Bayes estimates, we also consider the total
number of rare variants sijg (MAF <0.05) as a second
summary measure of the genetic information per
subject.
Phenotype model
Both the empirical Bayes estimates and the number of
rare variants in a specific gene can be plugged into the
models for the phenotypes to test for gene effects. To
model the longitudinal quantitative trait DBP, we use
the following linear mixed model for each gene g:
Yijt = μ + βxijt + γ1 ebijg + γ2sijg + uij + eijt, (2)
with sijg the number of rare variants within gene g, uij
a normally distributed random family effect, and eijt a
normally distributed residual with a T times T covar-
iance matrix to model the correlation between repeated
measurements within a person (unstructured covariance
error term). Here T is the number of time points. The
variance of the family effect uij is equal to variance τ
2
and the correlation of ui=(ui1....uini ) within a family of
size ni is assumed to be equal to 2 times the kinship
coefficient between the relatives (polygenic). Estimates
of all model parameters including the T(T+1)/2 para-
meters of the unstructured covariance matrix were
obtained by maximizing the likelihood function using
the optim function in R [7]. Based on Model (2) we can
test the null hypothesis of no gene effect, which is
equivalent to testing the null hypothesis H0: g1=g2 = 0.
We used a multivariate Wald statistic with 2 degrees of
freedom. In addition, to model time-dependent gene
effects we added interaction terms between the gene
effects (eb and s) and the time variable. The correspond-
ing multivariate Wald tests for association of a gene
(cross-sectional and over time) will have 2T degrees of
freedom; p-values smaller than 6 × 10-5 were considered
to be statistically significant (Bonferroni correction)




The maximum power was achieved for MAP4 gene
using the imputed files and restricting the analysis to
functional variants (96.5% power for the 2 degrees of
freedom test). For all variants based on imputed files the
power for this gene was only 36.5%. For functional var-
iants based on the VCF files the power was 72.5%.
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Indeed, the total percentage of variance explained by the
loci for MAP4 was largest among the genes at chromo-
some 3, namely 0.0648 of all associated genes.
To show the performance of our methods for various
genetic effects, we also provide each gene with func-
tional loci (Supplemental Table 1 of GAW18 answers)
the percentage of data sets with a p-value smaller than
0.05 in Table 1. The results for the univariate Wald
tests and the multivariate Wald tests are given. In addi-
tion to MAP4 gene, RYBP, ZBTB38, and GPR160 had in
more than 10% of the data sets a p-value smaller than
5% for the multivariate test. For RYBP and GPR160, the
sum of rare variants showed a better performance than
the empirical Bayes estimate. Indeed, RYBP has 2 func-
tional loci with MAFs less than 0.05, and GPR160 has
one functional locus with a MAF less than 0.05. For
ZBTB238 and MAP4, the empirical Bayes gene summary
performed better. Gene ZBTB238 has 2 functional loci
with MAFs less than 0.05. Because the effects are oppo-
site, the sum score has no power. Gene MAP4 has 12
functional loci with MAFs less than 0.05. Seven of these
loci carriers of the rare variant had a smaller DBP, and
5 loci carriers of the rare variant had a higher DBP than
noncarriers.
Overall, the percentage of genes with a significant
result at the 5% level appeared to be 7.1%.
Analysis of real data set
For the real data set, we did not find any significant
results when we used the imputed files. The smallest
p-value was 0.002 for gene COX17. When using the
VCF files, we identified a significant association between
FRMD4B and DBP (p-value = 8.3 × 10-12). The total
number of variants in this gene was 2348; 1388 SNPs
had MAFs smaller than 5%. The p-value for the empiri-
cal Bayes estimate was 5.3 × 10-6 and for the number of
rare variants, 0.057. When using the imputed files, the
p-value for this gene was only 0.32.
When we included an interaction term between the
gene summaries and time, we identified 2 more genes
showing borderline significance when using the VCF
files. The genes are MUSTN1 and GTDC2 with p-values
of 7.5 × 10-5 and 9.9 × 10-5, respectively. For both genes,
the association between the rare variants and DBP
Table 1 Power based on analysis of genes at chromosome 3 in simulated datasets.
Gene Number of variants % Variance of largest functional variant Power of eb1 Power of s2 Power of combined3
PDCD6I 466 0.00040 0.0 7.0 2.5
DNASE1L3 115 0.00014 2.0 4.5 1.5
PTPLB 493 0.00002 3.5 8.5 5.5
PAK2 409 0.00005 3.5 0.6 4.0
FBLN2 687 0.00008 0.5 3.0 0.5
FLNB 956 0.00085 11.0 5.0 7.0
VPS8 1042 0.00008 3.0 12.0 5.0
RYBP 347 0.00041 6.0 21.0 15.5
ZBTB38 590 0.00031 51.0 4.0 34.5
GPR160 2 44 0.00020 3.0 19.5 12.0
SERP1 18 0.00002 0.0 5.0 1.5
SUMF1 747 0.00010 2.0 1.0 1.0
NMNAT3 559 0.00011 5.0 5.5 6.5
ARF4 161 0.00004 1.5 3.5 2.0
MAP4 894 0.01222 99.0 30.5 97.0
MLH1 310 0.00007 2.5 2.0 1.5
ARHGEF3 2223 0.00007 2.0 5.0 3.0
PPP2R3A 1081 0.00025 0.5 1.0 1.0
MUC13 203 0.00007 5.0 0.5 3.0
RAD18 693 0.00003 3.0 3.5 3.5
SEMA3F 134 0.00004 12.0 7.5 6.5
BTD 291 0.00011 1.0 2.5 1.0
ABTB1 48 0.00053 3.5 1.1 6.5
B4GALT4 217 0.00004 2.0 4.5 3.0
The values represent the percentages of significant results at 5% level. Imputed data sets were used.
1 Empirical Bayes estimate H0:g1 = 0.
2 Number of rare variants H0:g2 = 0.
3 H0:g1 = 0 and g2 = 0.
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appears to be largest (smallest p-values). For MUSTN1,
the effect is most pronounced for the first time points;
for GTDC2, the association is most significant for the last
time points. The effect sizes are depicted in Figure 1. For
GTDC2, the parameter estimates for the eb gene sum-
mary increase over time.
Discussion
We used a 2-step procedure in which, first, the informa-
tion in a gene is summarized by 2 variables, namely the
empirical Bayes estimate capturing common variation and
the number of rare variants. In the second step, these
summaries are included as covariates in linear mixed mod-
els. Interactions such as time-gene summary can be
included. The results of the analysis of real data showed
that time-gene interactions may identify other genes.
Another advantage is that this method can deal with miss-
ing data. An alternative method is generalized estimating
equations (GEEs). However, existing R-modules do not
allow for flexible correlation structures, resulting in a con-
servative approach when the working correlation does not
agree with the true correlation structure. Moreover,
whereas the GEE method assumes complete missing at
random, mixed models are valid under the missing at ran-
dom assumption.
Using the linear mixed model without an interaction
effect between time and gene summaries for the real
data set, we identified one significant gene when using
the VCF file, FRMD4B. The association of this gene
appears to be biologically sound. It has been found to
be associated with heart failure [8]. Using the real data
set, we did not find any association using the imputed
data sets. Probably, the followed imputation procedure
provided noise. In addition, 2 genes showed borderline
significance when allowing the effect of the gene sum-
maries to change over time.
With regard to the power of the method, the power
was good only for MAP4. Restriction of the analysis to
functional variants improved the performance consider-
ably. This can be explained by the fact that in the simu-
lation model, only the “functional” loci are associated.
Note that for the real data, significant results were
obtained only when all SNPs were used. This shows that
restricting to functional variants may result in false
negatives.
The empirical Bayes summary appeared to perform
well. The sum of rare variants, however, does not per-
form well when variants have opposite effects. In addi-
tion, the sum score does not assign more weights to a
variant that segregates within the family compared with
a rare variant that occurs in several families. To include
this information in testing for association of rare var-
iants will require future research.
Conclusions
The 2-step approach is a flexible method for performing
a gene-based analysis: it can be used for any design and
can model time-dependent effects in longitudinal designs.
For this relatively small sample size, this approach was
able to detect genes that explain 0.0648% of the variance
(power of 97%). With regard to the real data set, the asso-
ciation between gene FRMD4B and DBP was significant
(p = 8.3 × 10-12).
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